ATE160377T1 - Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren - Google Patents

Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren

Info

Publication number
ATE160377T1
ATE160377T1 AT90908076T AT90908076T ATE160377T1 AT E160377 T1 ATE160377 T1 AT E160377T1 AT 90908076 T AT90908076 T AT 90908076T AT 90908076 T AT90908076 T AT 90908076T AT E160377 T1 ATE160377 T1 AT E160377T1
Authority
AT
Austria
Prior art keywords
viruses
sequences
recombination
proteins
genes
Prior art date
Application number
AT90908076T
Other languages
English (en)
Inventor
Linda R Gritz
Dennis L Panicali
Original Assignee
Applied Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Biotechnology Inc filed Critical Applied Biotechnology Inc
Application granted granted Critical
Publication of ATE160377T1 publication Critical patent/ATE160377T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT90908076T 1989-04-18 1990-04-17 Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren ATE160377T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34005289A 1989-04-18 1989-04-18

Publications (1)

Publication Number Publication Date
ATE160377T1 true ATE160377T1 (de) 1997-12-15

Family

ID=23331664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908076T ATE160377T1 (de) 1989-04-18 1990-04-17 Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren

Country Status (4)

Country Link
EP (1) EP0469089B1 (de)
AT (1) ATE160377T1 (de)
DE (1) DE69031735T2 (de)
WO (1) WO1990012880A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105383D0 (en) * 1991-03-14 1991-05-01 Immunology Ltd An immunotherapeutic for cervical cancer
FR2676071B1 (fr) * 1991-05-02 1994-11-18 Transgene Sa Nouveau variant gp160 non-clivable, soluble, de forme hybride.
US5686263A (en) * 1991-05-31 1997-11-11 Genentech, Inc. Method for enhancing gene expression
US5741492A (en) * 1996-01-23 1998-04-21 St. Jude Children's Research Hospital Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
US6723558B1 (en) 1996-01-23 2004-04-20 St. Jude Children's Research Hospital Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
CN102325888B (zh) 2008-11-21 2016-09-07 巴法里安诺迪克有限公司 包含多个同源核苷酸序列的载体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596585B2 (en) * 1985-03-18 1990-05-10 Genelabs Incorporated Hybrid genes (eg. ig's & mhc proteins) via lambda library andplasmid casette vector
FR2583429B1 (fr) * 1985-06-18 1989-11-03 Transgene Sa Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
NZ217645A (en) * 1985-09-25 1991-11-26 Oncogen Recombinant viruses expressing lav/htlv-iii related epitopes and vaccine formulations

Also Published As

Publication number Publication date
EP0469089B1 (de) 1997-11-19
DE69031735D1 (de) 1998-01-02
WO1990012880A1 (en) 1990-11-01
DE69031735T2 (de) 1998-03-12
EP0469089A1 (de) 1992-02-05

Similar Documents

Publication Publication Date Title
ATE97164T1 (de) Rekombinantes vaccinia-virus mva.
JP7326157B2 (ja) Ｈｂｖワクチン
AR003125A1 (es) Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
ES2167304T3 (es) Peptido que contiene el antigeno de superficie de la hepatitis b.
AR058249A2 (es) Una molecula aislada de polinucleotido que comprende una secuencia de adn que codifica una molecula infecciosa de arn que codifica un virus prrs norteamericano, celula transfectada y vacuna
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
BR9205771A (pt) Vetor de vírus recombinantes e processo para a fabricaçao do mesmo
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DK548079A (da) Rekombinations-dna-molekyler og fremgangsmaade til fremstilling deraf
DK217288D0 (da) Dna, der indkoder t-celleoverfladeproteinet t4, og anvendelse af t4-fragmenter ved behandling af aids
ES2099066T3 (es) Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1).
ES2191929T3 (es) Respuestas inmunologicas contra los antigenos pvh estimuladas por composiciones que comprenden un antigeno pvh y una proteina de estres o un vector de expresion capaz de expresar dichas proteinas.
ATE359084T1 (de) Modifizierter hitzeschockprotein/peptidantigen komplex
CY1108212T1 (el) Αντιγονα συγγενη με το α-33 και οι φαρμακολογικες τους χρησεις
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DE3853139D1 (de) Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
ATE160377T1 (de) Erzeugung von hybrid-genen und proteinen durch rekombination mittels viren
ES8304204A1 (es) Un metodo de producir un polipeptido que presenta la especialidad de los antigenos virales de la glosopeda (fmo).
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
ES529225A0 (es) Un procedimiento para preparar un organismo unicelular que tiene una secuencia de adn que codifica un plipeptid0 que tiene un determinante inmunorreactivo u antigeno de una glicoproteina de virus de herpes simplex.
DE69318716D1 (de) Anti-Katze Immundefiziensvirus (FIV) Impfstoffe
EP0236977A3 (de) Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera
ES2085163T3 (es) Vacunas contra los parasitos metazoos.
Peng et al. Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity
CU22666A1 (es) Procedimiento para la expresión de genes de los virus del dengue en la levadura pichia pastoris, adns recombinantes y microorganismos transformados